Company
Beta Bionics
Nasdaq: BBNX
Irvine, California device maker, spun out of a Boston University bionic-pancreas lab in 2015. Builds automated insulin delivery.
1 story
Regulatory News has published 1 story about Beta Bionics on 15 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 15 September 2026.
This page is generated from Regulatory News’ editorial coverage of Beta Bionics. It is not an advertisement.
On the record
- Company
- Beta Bionics, Inc. (Nasdaq: BBNX)
- Headquarters
- Irvine, California
- Founded
- 2015, Boston — from Ed Damiano’s bionic-pancreas lab at Boston University
- Regulator
- U.S. Food and Drug Administration (CDRH)
- Latest milestone
- FDA 510(k) clearance, Mint patch pump
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
